在禁欲期间持续的吗啡记忆在雌性中,但不是雄性,甲基胺5受体淘汰赛小鼠
Erin McLemon1, Georgia Watt1, Rossana Rosa Porto1
1School of Medicine, Western Sydney University, Campbelltown, NSW, Australia.
Progress in neuro-psychopharmacology & biological psychiatry
|February 25, 2026
概括
在雄性和雌性小鼠中,甲基胺5受体 (mGlu5) 删除对吗啡奖励的影响不同. 这突出了阿片类药物使用障碍中性别特异性的作用,并建议mGlu5作为治疗点.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 成研究 研究成研究
背景情况:
- 阿片类药物使用障碍 (OUD) 是一种慢性复发性疾病,易感性因性别有差异.
- 对OUD的有限有效治疗需要新的治疗点.
- 甲基氨酸5受体 (mGlu5) 与阿片类药物奖励有关,但其性别特异性作用尚不清楚.
研究的目的:
- 调查mGlu5在吗啡奖励和运动运动活动中的性别特异性作用.
- 检查mGlu5删除对雄性和雌性小鼠的吗啡诱导条件位置偏好 (CPP) 的影响.
主要方法:
- 使用了两种性别的mGlu5淘汰赛 (KO) 和野生型 (WT) 小鼠.
- 在不同的剂量下评估了吗啡诱导的CPP和运动运动活性.
- 分析了mGlu5删除的剂量和性别相关效应.
主要成果:
- 雌性mGlu5 KO小鼠表现出持续的吗啡 (5 mg/kg) 奖励记忆,与雌性WT小鼠不同.
- 雄性WT小鼠表现出持续的吗啡 (10毫克/公斤) 奖励记忆,在雄性mGlu5 KO小鼠中缺席.
- 吗啡对KO小鼠和WT小鼠的运动影响不同,在两性中都观察到剂量依赖的效应.
结论:
- mGlu5在调节吗啡的奖励和运动效应方面发挥着性别特异性的作用.
- 临床前的OUD模型必须包括两性,以了解这些差异.
- mGlu5为OUD提供了潜在的治疗标,特别是在减少女性复发风险方面.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.2K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.2K
Analgesia and Pain Management
2.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.4K
Opioid Receptors: Overview
5.4K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
5.4K


